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Increasing numbers of HIV infected patients along with
severe treatment-associated complications and related
deaths make the AIDS pandemic [1]. These inhibitors
reduced the virus proliferation and this success made the
HIV aspartic protease the prime target for AIDS therapies
[2]. In this study, we present the first account of pentacy-
cloundecane (PCU) lactam-peptide based HIV protease
inhibitors with nanomolar activity against the resistance-
prone wild type C-South African HIV-protease (C-SA).
NMR and molecular docking were employed to determine
a logical correlation between the inhibitory concentration
(IC50) results and the 3D structure of the corresponding
inhibitors in solution. NMR investigations indicated that
the activity is related to the chirality of the PCU moiety and
its ability to induce conformations of the coupled peptide
side chain. In addition, docking studies confirmed the
observed EASY-ROESY results and the experimental IC50
activity profile of the considered inhibitors. Due to theoreti-
cal importance of nuclear quadrupole resonance data [3] for
characterization of molecular dynamics, DFT calculations
are carried out to obtain 17O and 14N- NQR parameters.
The studies reported in this work were undertaken to estab-
lish whether the NQR method could be used to derive a
rational structure-activity relationship for these inhibitors.
These findings open up useful applications for this family of
inhibitors, considering the vast number of alternative dis-
ease related proteases that may exist.
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